Sanofi (BIT:1SAN)

Market Cap	99.57B
Revenue (ttm)	45.74B
Net Income (ttm)	9.13B
Shares Out	n/a
EPS (ttm)	7.36
PE Ratio	10.91
Forward PE	10.04
Dividend	3.92 (4.89%)
Ex-Dividend Date	May 12, 2025

Volume	847
Average Volume	1,897
Open	81.42
Previous Close	81.52
Day's Range	81.20 - 81.84
52-Week Range	76.82 - 111.00
Beta	0.41
RSI	47.40
Earnings Date	Jul 31, 2025

About Ligand Pharmaceuticals

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SAN

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.